Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ixodes | 2 | 2022 | 40 | 1.590 |
Why?
|
Skin Neoplasms | 15 | 2024 | 5797 | 0.960 |
Why?
|
Communicable Diseases | 2 | 2023 | 879 | 0.870 |
Why?
|
Polyporales | 1 | 2022 | 6 | 0.820 |
Why?
|
Scedosporium | 1 | 2021 | 10 | 0.800 |
Why?
|
SOXB1 Transcription Factors | 3 | 2011 | 286 | 0.720 |
Why?
|
Histological Techniques | 1 | 2020 | 194 | 0.710 |
Why?
|
Rhinosporidiosis | 1 | 2019 | 1 | 0.690 |
Why?
|
Rhinosporidium | 1 | 2019 | 1 | 0.690 |
Why?
|
Pathology | 1 | 2023 | 270 | 0.690 |
Why?
|
Microbiological Techniques | 1 | 2020 | 98 | 0.680 |
Why?
|
Pathology, Clinical | 1 | 2023 | 375 | 0.660 |
Why?
|
Mycoses | 1 | 2022 | 387 | 0.630 |
Why?
|
Melanoma | 11 | 2023 | 5695 | 0.630 |
Why?
|
Mycobacterium Infections | 2 | 2021 | 121 | 0.620 |
Why?
|
Skin | 6 | 2024 | 4468 | 0.610 |
Why?
|
Dermatomyositis | 2 | 2020 | 256 | 0.590 |
Why?
|
Carcinoma, Basal Cell | 2 | 2020 | 559 | 0.580 |
Why?
|
Hand, Foot and Mouth Disease | 1 | 2016 | 25 | 0.540 |
Why?
|
Coxsackievirus Infections | 1 | 2016 | 42 | 0.540 |
Why?
|
Enterovirus A, Human | 1 | 2016 | 27 | 0.540 |
Why?
|
Scleroderma, Localized | 1 | 2017 | 87 | 0.540 |
Why?
|
Blood Specimen Collection | 2 | 2008 | 238 | 0.530 |
Why?
|
Hemolysis | 2 | 2008 | 423 | 0.500 |
Why?
|
Staining and Labeling | 2 | 2017 | 1090 | 0.440 |
Why?
|
Gnathostomiasis | 1 | 2012 | 1 | 0.430 |
Why?
|
Cytodiagnosis | 1 | 2017 | 432 | 0.420 |
Why?
|
Skin Diseases, Parasitic | 1 | 2012 | 13 | 0.420 |
Why?
|
Albendazole | 1 | 2012 | 50 | 0.420 |
Why?
|
Ivermectin | 1 | 2012 | 47 | 0.410 |
Why?
|
Antiparasitic Agents | 1 | 2012 | 43 | 0.410 |
Why?
|
Immunohistochemistry | 10 | 2021 | 11064 | 0.400 |
Why?
|
Epidermodysplasia Verruciformis | 2 | 2024 | 22 | 0.390 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2015 | 387 | 0.370 |
Why?
|
Larva | 1 | 2012 | 509 | 0.360 |
Why?
|
Virus Diseases | 1 | 2017 | 721 | 0.360 |
Why?
|
Intermediate Filament Proteins | 1 | 2011 | 263 | 0.350 |
Why?
|
Merkel Cells | 1 | 2009 | 24 | 0.350 |
Why?
|
Blood Coagulation Tests | 2 | 2008 | 270 | 0.320 |
Why?
|
Psoriasis | 2 | 2023 | 939 | 0.320 |
Why?
|
Factor V Deficiency | 1 | 2008 | 10 | 0.320 |
Why?
|
Nevus, Pigmented | 1 | 2011 | 221 | 0.320 |
Why?
|
Sweat Gland Neoplasms | 2 | 2024 | 117 | 0.310 |
Why?
|
Papillomavirus Infections | 2 | 2024 | 1600 | 0.310 |
Why?
|
Skin Diseases | 1 | 2017 | 1089 | 0.310 |
Why?
|
Health Personnel | 1 | 2022 | 3310 | 0.300 |
Why?
|
Hemangiopericytoma | 1 | 2008 | 71 | 0.300 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2008 | 100 | 0.300 |
Why?
|
Immunocompromised Host | 3 | 2022 | 857 | 0.300 |
Why?
|
Plasma Exchange | 1 | 2008 | 158 | 0.290 |
Why?
|
Blood Banks | 1 | 2008 | 108 | 0.290 |
Why?
|
Nevus | 2 | 2023 | 205 | 0.290 |
Why?
|
Skin Aging | 1 | 2009 | 141 | 0.290 |
Why?
|
Melanocytes | 1 | 2009 | 512 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 2823 | 0.260 |
Why?
|
Exanthema | 2 | 2023 | 504 | 0.250 |
Why?
|
Autoimmune Diseases | 1 | 2017 | 2250 | 0.240 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 2160 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 4024 | 0.220 |
Why?
|
Spondylarthropathies | 1 | 2023 | 14 | 0.220 |
Why?
|
Skin Diseases, Genetic | 1 | 2024 | 49 | 0.220 |
Why?
|
Edema | 2 | 2021 | 772 | 0.220 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2023 | 63 | 0.220 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 600 | 0.210 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2023 | 85 | 0.210 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2018 | 0.200 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.200 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11141 | 0.200 |
Why?
|
Humans | 56 | 2024 | 760261 | 0.200 |
Why?
|
Hyphae | 1 | 2021 | 52 | 0.200 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 218 | 0.190 |
Why?
|
Sclerosis | 1 | 2021 | 210 | 0.190 |
Why?
|
Neoplasms, Fibroepithelial | 1 | 2020 | 8 | 0.180 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 376 | 0.180 |
Why?
|
Africa | 1 | 2023 | 707 | 0.180 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1799 | 0.180 |
Why?
|
Hyperpigmentation | 1 | 2021 | 117 | 0.170 |
Why?
|
Skin Pigmentation | 1 | 2021 | 277 | 0.170 |
Why?
|
Soft Tissue Neoplasms | 1 | 2008 | 1151 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 311 | 0.160 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3618 | 0.160 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4409 | 0.150 |
Why?
|
Panniculitis, Lupus Erythematosus | 1 | 2017 | 5 | 0.150 |
Why?
|
Thiosulfates | 1 | 2017 | 53 | 0.150 |
Why?
|
Skin Diseases, Bacterial | 1 | 2017 | 68 | 0.140 |
Why?
|
Frozen Sections | 1 | 2017 | 153 | 0.140 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2012 | 321 | 0.140 |
Why?
|
Rwanda | 1 | 2019 | 662 | 0.140 |
Why?
|
Mice, SCID | 3 | 2011 | 2627 | 0.140 |
Why?
|
Antifungal Agents | 1 | 2021 | 746 | 0.140 |
Why?
|
Lymphatic Metastasis | 2 | 2015 | 2945 | 0.140 |
Why?
|
Papillomaviridae | 2 | 2024 | 1117 | 0.140 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2016 | 42 | 0.130 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2015 | 22 | 0.130 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2020 | 640 | 0.130 |
Why?
|
Soft Tissue Infections | 1 | 2017 | 168 | 0.130 |
Why?
|
Lyme Disease | 1 | 2022 | 630 | 0.130 |
Why?
|
Adenoma, Sweat Gland | 1 | 2015 | 17 | 0.130 |
Why?
|
Vulvar Neoplasms | 1 | 2018 | 265 | 0.130 |
Why?
|
Biopsy | 5 | 2024 | 6775 | 0.130 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1006 | 0.130 |
Why?
|
Wounds and Injuries | 1 | 2008 | 2477 | 0.130 |
Why?
|
Endocarditis, Bacterial | 1 | 2019 | 445 | 0.120 |
Why?
|
Mitotic Index | 1 | 2015 | 161 | 0.120 |
Why?
|
Isoantibodies | 2 | 2008 | 661 | 0.120 |
Why?
|
Salivary Gland Neoplasms | 1 | 2018 | 304 | 0.120 |
Why?
|
Rosaniline Dyes | 1 | 2014 | 48 | 0.120 |
Why?
|
Facial Neoplasms | 1 | 2015 | 125 | 0.120 |
Why?
|
Search Engine | 1 | 2015 | 140 | 0.120 |
Why?
|
Galectin 1 | 1 | 2015 | 128 | 0.110 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2014 | 61 | 0.110 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 103 | 0.110 |
Why?
|
Lichen Planus | 1 | 2014 | 71 | 0.110 |
Why?
|
Myelodysplastic Syndromes | 1 | 2024 | 1401 | 0.110 |
Why?
|
Connective Tissue Diseases | 1 | 2017 | 286 | 0.110 |
Why?
|
Animals | 11 | 2022 | 167940 | 0.110 |
Why?
|
Calciphylaxis | 1 | 2015 | 130 | 0.110 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9196 | 0.110 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12968 | 0.110 |
Why?
|
Cytosine | 1 | 2014 | 212 | 0.110 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2014 | 173 | 0.110 |
Why?
|
Middle Aged | 21 | 2024 | 220175 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2021 | 80301 | 0.110 |
Why?
|
Panniculitis | 1 | 2012 | 45 | 0.100 |
Why?
|
Female | 24 | 2023 | 391011 | 0.100 |
Why?
|
Pemphigoid, Bullous | 1 | 2013 | 114 | 0.100 |
Why?
|
Male | 20 | 2024 | 359413 | 0.100 |
Why?
|
Subcutaneous Tissue | 1 | 2012 | 132 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18134 | 0.100 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2011 | 138 | 0.100 |
Why?
|
Facial Transplantation | 1 | 2014 | 221 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2359 | 0.090 |
Why?
|
Polyomavirus Infections | 1 | 2012 | 195 | 0.090 |
Why?
|
Education, Medical | 1 | 2022 | 1728 | 0.090 |
Why?
|
Alopecia | 1 | 2014 | 415 | 0.090 |
Why?
|
United States | 3 | 2023 | 72363 | 0.090 |
Why?
|
Lymphoma, T-Cell | 1 | 2012 | 305 | 0.090 |
Why?
|
Tumor Virus Infections | 1 | 2012 | 438 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1905 | 0.080 |
Why?
|
Behcet Syndrome | 1 | 2010 | 86 | 0.080 |
Why?
|
Curriculum | 1 | 2023 | 3722 | 0.080 |
Why?
|
Probability | 1 | 2015 | 2476 | 0.080 |
Why?
|
Adult | 16 | 2021 | 219847 | 0.080 |
Why?
|
Medical Oncology | 2 | 2015 | 2321 | 0.080 |
Why?
|
Calcinosis | 1 | 2017 | 1478 | 0.080 |
Why?
|
Cicatrix | 1 | 2014 | 781 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2016 | 8498 | 0.080 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2008 | 65 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2015 | 20048 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2011 | 4891 | 0.070 |
Why?
|
P-Selectin | 1 | 2010 | 600 | 0.070 |
Why?
|
Tumor Cells, Cultured | 2 | 2015 | 6131 | 0.070 |
Why?
|
Diagnostic Errors | 1 | 2014 | 1266 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2022 | 3967 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1892 | 0.070 |
Why?
|
Sunlight | 1 | 2009 | 337 | 0.070 |
Why?
|
Plasma Cells | 1 | 2010 | 592 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58947 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 5248 | 0.070 |
Why?
|
Prothrombin Time | 1 | 2006 | 116 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14656 | 0.070 |
Why?
|
Aged | 12 | 2024 | 168995 | 0.070 |
Why?
|
Myosin Heavy Chains | 1 | 2008 | 402 | 0.070 |
Why?
|
Stem Cell Niche | 1 | 2009 | 346 | 0.070 |
Why?
|
Blood Donors | 1 | 2008 | 343 | 0.070 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2013 | 1094 | 0.070 |
Why?
|
Radiation Injuries | 1 | 2013 | 1183 | 0.070 |
Why?
|
Partial Thromboplastin Time | 1 | 2006 | 206 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 3 | 2015 | 2473 | 0.060 |
Why?
|
ABO Blood-Group System | 1 | 2008 | 369 | 0.060 |
Why?
|
Mouth Mucosa | 1 | 2008 | 426 | 0.060 |
Why?
|
Eosinophils | 1 | 2010 | 946 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2852 | 0.060 |
Why?
|
Plasma | 1 | 2008 | 584 | 0.060 |
Why?
|
Dermatology | 1 | 2015 | 914 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3466 | 0.060 |
Why?
|
Nose | 1 | 2008 | 519 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2005 | 13249 | 0.060 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2024 | 88 | 0.060 |
Why?
|
Ultraviolet Rays | 1 | 2009 | 1078 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3011 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2008 | 1066 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2015 | 6242 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2008 | 1134 | 0.050 |
Why?
|
HLA Antigens | 1 | 2008 | 1369 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2014 | 3491 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1347 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2378 | 0.050 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 416 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1262 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11708 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2696 | 0.050 |
Why?
|
Immunoenzyme Techniques | 1 | 2005 | 1705 | 0.050 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 180 | 0.050 |
Why?
|
Mutation | 4 | 2024 | 29950 | 0.050 |
Why?
|
Ointments | 1 | 2021 | 58 | 0.050 |
Why?
|
Cell Count | 1 | 2005 | 1838 | 0.050 |
Why?
|
Communication | 1 | 2015 | 3846 | 0.050 |
Why?
|
Transcription Factors | 4 | 2022 | 12100 | 0.050 |
Why?
|
Actins | 1 | 2008 | 2049 | 0.050 |
Why?
|
Pleural Neoplasms | 1 | 2005 | 609 | 0.050 |
Why?
|
Gene Fusion | 1 | 2023 | 354 | 0.040 |
Why?
|
Graft Rejection | 1 | 2014 | 4423 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15273 | 0.040 |
Why?
|
Child | 3 | 2021 | 79758 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6545 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2641 | 0.040 |
Why?
|
Calcitriol | 1 | 2021 | 297 | 0.040 |
Why?
|
Recurrence | 2 | 2012 | 8487 | 0.040 |
Why?
|
Hair Diseases | 1 | 2020 | 72 | 0.040 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 259 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21065 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2021 | 711 | 0.040 |
Why?
|
Mesothelioma | 1 | 2005 | 806 | 0.040 |
Why?
|
Lymphoid Tissue | 1 | 2021 | 446 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2015 | 10434 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4357 | 0.040 |
Why?
|
Mice | 5 | 2015 | 81216 | 0.040 |
Why?
|
Paraffin Embedding | 1 | 2019 | 302 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2023 | 1122 | 0.040 |
Why?
|
Vulva | 1 | 2018 | 82 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7468 | 0.040 |
Why?
|
beta Catenin | 1 | 2023 | 1043 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3278 | 0.040 |
Why?
|
Crohn Disease | 1 | 2010 | 2275 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 3023 | 0.040 |
Why?
|
Dermatologic Agents | 1 | 2021 | 306 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 698 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2015 | 22041 | 0.040 |
Why?
|
Translocation, Genetic | 1 | 2022 | 1388 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2017 | 278 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4717 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10183 | 0.030 |
Why?
|
Ligands | 2 | 2015 | 3277 | 0.030 |
Why?
|
PubMed | 1 | 2015 | 128 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 2010 | 3763 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 2 | 2012 | 1056 | 0.030 |
Why?
|
Receptor, Notch2 | 1 | 2015 | 87 | 0.030 |
Why?
|
Adolescent | 2 | 2021 | 87747 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1455 | 0.030 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2015 | 93 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 18968 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2014 | 146 | 0.030 |
Why?
|
Disease Progression | 1 | 2010 | 13505 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1843 | 0.030 |
Why?
|
Lower Extremity | 1 | 2021 | 1196 | 0.030 |
Why?
|
Necrosis | 1 | 2017 | 1612 | 0.030 |
Why?
|
Sampling Studies | 1 | 2014 | 614 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1890 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2016 | 16905 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 562 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7268 | 0.030 |
Why?
|
Erythema | 1 | 2013 | 262 | 0.030 |
Why?
|
Risk Factors | 1 | 2019 | 74269 | 0.030 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2012 | 257 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2016 | 721 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2015 | 495 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 586 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2804 | 0.020 |
Why?
|
Survival Rate | 1 | 2005 | 12806 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 64947 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 896 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2014 | 727 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1006 | 0.020 |
Why?
|
Vascular Malformations | 1 | 2015 | 464 | 0.020 |
Why?
|
Young Adult | 2 | 2021 | 58673 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1668 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1633 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2008 | 7809 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9283 | 0.020 |
Why?
|
Gene Dosage | 1 | 2012 | 1218 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2014 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2012 | 612 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5039 | 0.020 |
Why?
|
Oncogenes | 1 | 2012 | 1221 | 0.020 |
Why?
|
Face | 1 | 2012 | 1017 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2866 | 0.020 |
Why?
|
Prognosis | 1 | 2005 | 29636 | 0.010 |
Why?
|
Breast | 1 | 2013 | 1980 | 0.010 |
Why?
|
Zebrafish | 1 | 2016 | 2996 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22025 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2927 | 0.010 |
Why?
|
Tissue Donors | 1 | 2014 | 2314 | 0.010 |
Why?
|
Pleura | 1 | 2005 | 243 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4109 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1601 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12447 | 0.010 |
Why?
|
Keratins | 1 | 2005 | 497 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3074 | 0.010 |
Why?
|
Cell Movement | 1 | 2015 | 5206 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9989 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 1811 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7593 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4814 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1882 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6226 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3145 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17766 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5498 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2010 | 3731 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9388 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4437 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12959 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42034 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6457 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2005 | 2441 | 0.010 |
Why?
|
Trans-Activators | 1 | 2005 | 2861 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14396 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39254 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2005 | 5793 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20484 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9590 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2005 | 11480 | 0.000 |
Why?
|